Top

Published in:

01-12-2009 | 2009 SSAT Poster Presentation

Intestinal Surgery for Crohn’s Disease: Predictors of Recovery, Quality of Life, and Costs

Authors: Marco Scarpa, Cesare Ruffolo, Domenico Bassi, Riccardo Boetto, Renata D’Incà, Andrea Buda, Giacomo C. Sturniolo, Imerio Angriman

Published in: Journal of Gastrointestinal Surgery | Issue 12/2009

Abstract

Introduction

The aim of this prospective study was to analyze the impact of different surgical techniques on patients undergoing intestinal surgery for Crohn’s disease (CD) in terms of recovery, quality of life, and direct and indirect costs.

Patients and methods

Forty-seven consecutive patients admitted for intestinal surgery for CD were enrolled in this prospective study. Surgical procedures were evaluated as possible predictors of outcome in terms of disability status (Barthel’s Index), quality of life (Cleveland Global Quality of Life score), body image, disease activity (Harvey–Bradshaw Activity Index), and costs (calculated in 2008 Euros). Univariate and multivariate analyses were performed.

Results

Significant predictors of a long postoperative hospital stay were the creation of a stoma, postoperative complications, disability status on the third post-operative day, and surgical access (R ² = 0.59, p < 0.01). Barthel’s index at discharge was independently predicted by laparoscopic-assisted approach, ileal CD, and colonic CD (R ² = 0.53, p < 0.01). The disability status at admission showed to be an independent predictor of quality of life score at follow-up. The overall cost for intestinal surgery for CD was 12,037 (10,117–15,795) euro per patient and stoma creation revealed to be its only predictor (p = 0.006).

Conclusions

Laparoscopy was associated with a shorter postoperative length of stay; stoma creation was associated with a long and expensive postoperative hospital stay, and stricturoplasty was associated with a slower recovery of bowel function.

Singleton JW, Law DH, Kelley ML Jr, Mekhjian HS, Sturdevant RA. National Cooperative Crohn’s Disease Study: adverse reactions to study drugs. Gastroenterology 1979;77:870–882.PubMed

Mussell M, Bocker U, Nagel N, Singer MV. Predictors of disease-related concerns and other aspects of health-related quality of life in outpatients with inflammatory bowel disease. Eur J Gastroenterol Hepatol 2004;16:1273–1280.CrossRefPubMed

Etienney I, Bouhnik Y, Gendre JP, Lemann M, Cosnes J, Matuchansky C, Beaugerie L, Modigliani R, Rambaud JC. Crohn’s disease over 20 years after diagnosis in a referral population. Gastroenterol Clin Biol 2004;28:1233–1239.PubMedCrossRef

Canavan C, Abrams KR, Hawthorne B, Drossman D, Mayberry JF. Long-term prognosis in Crohn’s disease: factors that affect quality of life. Aliment Pharmacol Ther 2006;23:377–385.CrossRefPubMed

Tillinger W, Mittermaier C, Lochs H, Moser G. Health-related quality of life in patients with Crohn’s disease. Influence of surgical operation—a prospective trial. Dig Dis Sci 1999;44:932–938.CrossRefPubMed

Thirlby RC, Land JC, Fenster LF, Lonborg L. Effect of surgery on health related quality of life in patients with inflammatory bowel disease. Arch Surg 1998;133:826–832.CrossRefPubMed

Yazdanpanah Y, Klein O, Gambiez L, Baron P, Desreumaux P, Marquis P, Cortot A, Quandalle P, Colombel JF. Impact of surgery on quality of life in Crohn’s disease. Am J Gastroenterol 1997;92:1897–1900.PubMed

Delaney CP, Kiran RP, Senagore AJ, O'Brien-Ermlich B, Church J, Hull TL, Remzi FH, Fazio VW. Quality of life improves within 30 days of surgery for Crohn’s disease. J Am Coll Surg 2003;196:714–721.CrossRefPubMed

Cohen RD, Larson LR, Roth JM, Becker RV, Mummert LL. The cost of hospitalisation in Crohn’s disease. Am J Gastroenterology 2000;95:524–530.CrossRef

10.

Blomqvist P, Ekbom A. Inflammatory bowel disease: health care and costs in Sweden in 1994. Scand J Gastrenterol 1997;32:1134–1139.CrossRef

11.

Bernstein CN, Papineau N, Zajaczkowski J, Rawsthorne P, Okrusko G, Blanchard JF. Direct hospital costs for patients with inflammatory bowel disease in a Canadian tertiary care university hospital. Am J Gastroenterol 2000;95:677–683.CrossRefPubMed

12.

Silverstein MD, Loftus EV, Sandborn WJ, Tremaine WJ, Feagan BG, Nietert PJ, Harmsen WS, Zinsmeister AR. Clinical course and costs of care for Crohn’s disease: Markov Model analysis of a population-based cohort. Gastroenterology 1999;117:49–57.CrossRefPubMed

13.

Bodger K. Cost of illness of Crohn’s disease. Pharmacoeconomics 2002;20:639–652.CrossRefPubMed

14.

Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989;170:2–6.CrossRefPubMed

15.

Harvey RF, Bradshaw JM. A simple index of Crohn’s disease activity. Lancet 1980;1(8167):514.CrossRefPubMed

16.

Mahoney FI, Barthel DW. Functional evaluation: the Barthel Index. MD State Med J 1965;14:61–65.PubMed

17.

Wade DT, Hewer RL. Functional abilities after stroke: measurement, natural history and prognosis. J Neurol Neurosurg Psychiatry 1987;50:177–182.CrossRefPubMed

18.

Kiran RP, Delaney CP, Senagore AJ, O'Brien-Ermlich B, Mascha E, Thornton J, Fazio VW. Prospective assessment of Cleveland Global Quality of Life and disease activity in Crohn’s disease. Am J Gastroenterol 2003;98:1783–1789.CrossRefPubMed

19.

Scarpa M, Ruffolo C, D'Incà R, Filosa T, Bertin E, Ferraro S, Polese L, Martin A, Sturniolo GC, Frego M, D'Amico DF, Angriman I. Health related quality of life after ileo-colonic resection for Crohn’s disease: long-term results. Inflamm Bowel Dis 2007;13:462–469.CrossRefPubMed

20.

Scarpa M, Ruffolo C, Polese L, Martin A, D’Incà R, Sturniolo GC, D’Amico DF, Angriman I. Quality of life after restorative proctocolectomy for ulcerative colitis: different questionnaires lead to different interpretations. Arch Surg 2007;142:158–165.CrossRefPubMed

21.

Dunker MS, Stiggelbout AM, van Hogezand RA, Ringers J, Griffioen G, Bemelman WA. Cosmesis and body image after laparoscopic-assisted and open ileocolic resection for Crohn’s disease. Surg Endosc 1998;12:1334–1340.CrossRefPubMed

22.

Maartense S, Dunker MS, Slors JF, Cuesta MA, Pierik EG, Gouma DJ, Hommes DW, Sprangers MA, Bemelman WA. Laparoscopic-assisted versus open ileocolic resection for Crohn's disease: a randomized trial. Ann Surg 2006;243:143–149.CrossRefPubMed

23.

McLeod RS, Churchill DN, Lock AM. Quality of life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology 1991;101:1307–1313.PubMed

24.

Guillou PJ, Windsor AJ, Nejim A. The health care economic implications of minimal access gastrointestinal surgery. In Bodger K, Daly MJ, Heatley RV, eds. Clinical economics in gastroenterology, 1st ed. Oxford: Blackwell Science Ltd, 2000, pp 133–145.

25.

Scarpa M, Sadocchi L, Ruffolo C, Iacobone M, Filosa T, Prando D, Polese L, Frego M, D'Amico DF, Angriman I. Rod in loop ileostomy: just an insignificant detail for ileostomy-related complications? Langenbecks Arch Surg 2007;392:149–154.CrossRefPubMed

26.

Drossman DA, Patrick DL, Mitchell CM, Zagami E, Applebaum MI. Health-related quality of life in inflammatory bowel disease. Dig Dis Sci 1989;34:1379–1386.CrossRefPubMed

27.

Blondel-Kucharski F, Chircop C, Marquis P, Cortot A, Baron F, Gendre JP, Colombel JF, Groupe d'Etudes Thérapeutique des Affections Inflammatoires Digestives (GETAID). Health-related quality of life in Crohn’s disease: a prospective study in 231 patients. Am J Gastroenterol 2001;96:2915–2920.CrossRefPubMed

28.

Fearnhead NS, Chowdhury R, Box B, George BD, Jewell DP, Mortensen NJ. Long-term follow-up of stricturoplasty for Crohn's disease. Br J Surg. 2006;93:475–482.CrossRefPubMed

29.

Yamamoto T, Fazio VW, Tekkis PP. Safety and efficacy of stricturoplasty for Crohn's disease: a systematic review and meta-analysis. Dis Colon Rectum 2007;50:1968–1986.CrossRefPubMed

30.

Broering DC, Eisenberger CF, Koch A, Bloechle C, Knoefel WT, Izbicki JR. Quality of life after surgical therapy of small bowel stenosis in Crohn's disease. Dig Surg 2001;18:124–130.CrossRefPubMed

Title: Intestinal Surgery for Crohn’s Disease: Predictors of Recovery, Quality of Life, and Costs
Authors: Marco Scarpa
Cesare Ruffolo
Domenico Bassi
Riccardo Boetto
Renata D’Incà
Andrea Buda
Giacomo C. Sturniolo
Imerio Angriman
Publication date: 01-12-2009
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 12/2009
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-009-1044-y

At a glance: The STEP trials

Springer Medicine

Intestinal Surgery for Crohn’s Disease: Predictors of Recovery, Quality of Life, and Costs

Abstract

Introduction

Patients and methods

Results

Conclusions

At a glance: The STEP trials

Springer Medicine

Abstract

Introduction

Patients and methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 12/2009

Right Colonic Perforation in an Asian Population: Predictors of Morbidity and Mortality

The National Mortality Burden and Significant Factors Associated with Open and Laparoscopic Cholecystectomy: 1997–2006

Does the Value of PET-CT Extend Beyond Pretreatment Staging? An Analysis of Survival in Surgical Patients with Esophageal Cancer

Repeat Curative Intent Liver Surgery is Safe and Effective for Recurrent Colorectal Liver Metastasis: Results from an International Multi-institutional Analysis

Preoperative Nomogram to Predict Risk of Perioperative Mortality Following Pancreatic Resections for Malignancy

The Secretory Phospholipase A2 Gene is Required for Gastroesophageal Reflux-Related Changes in Murine Esophagus